Pulmonx (LUNG) Consolidated Net Income (2019 - 2025)
Pulmonx (LUNG) has disclosed Consolidated Net Income for 7 consecutive years, with -$14.0 million as the latest value for Q3 2025.
- Quarterly Consolidated Net Income rose 1.41% to -$14.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$56.7 million through Sep 2025, up 0.81% year-over-year, with the annual reading at -$56.4 million for FY2024, 7.31% up from the prior year.
- Consolidated Net Income for Q3 2025 was -$14.0 million at Pulmonx, up from -$15.2 million in the prior quarter.
- The five-year high for Consolidated Net Income was -$10.2 million in Q3 2021, with the low at -$16.2 million in Q2 2023.
- Average Consolidated Net Income over 5 years is -$14.1 million, with a median of -$14.2 million recorded in 2022.
- The sharpest move saw Consolidated Net Income plummeted 163.76% in 2021, then grew 13.18% in 2024.
- Over 5 years, Consolidated Net Income stood at -$13.0 million in 2021, then decreased by 9.82% to -$14.3 million in 2022, then rose by 2.6% to -$13.9 million in 2023, then increased by 5.56% to -$13.1 million in 2024, then decreased by 6.2% to -$14.0 million in 2025.
- According to Business Quant data, Consolidated Net Income over the past three periods came in at -$14.0 million, -$15.2 million, and -$14.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.